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A facile and efficient protocol for the synthesis of novel imidazo[1,2-a]pyridines has been 
developed by one-pot reaction of aromatic aldehydes with 2-amino-5-chloropyridine and tert-
butylisocyanide in the presence of I2 in toluene at 70 
°
C. The present approach offers the 
advantages of simple methodology, clean, high atom-economy, mild condition, short reaction 
time, wide substrate scope, low environmental impact and high yield.  
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Introduction 
Multi-component synthesis have received considerable attention of organic chemists and 
emerged as a powerful tool for the construction of novel and complex molecular structures due to 
their advantages over conventional multistep synthesis. The major advantages of MCR’s include 
low cost, shorter reaction times, high atom economy, energy saving and avoidance of time 
consuming and expensive protection, deprotection, isolation and purification process
1
. 
The synthesis of fused bicyclic imidazo[1,2-a]pyridines is an important synthetic reaction 
as these scaffolds are found to form a very important core in numerous synthetic,  
pharmaceuticals and a wide variety of biologically active compounds
2
. A large number of 
compounds bearing imidazo[1,2-a]pyridines scaffolds have entered preclinical and clinical trials 





































































over the last few years. Many commercially available drugs (Figure 1) including, alpidem 
(anxiolytic), minodronic acid (to treat anxiety, heart failure and osteoporosis), olprinone 
(cardiotonic agent), optically active GSK 812397 candidate (HIV infection), saripidem (sedative 
and anxiolytic), zolimidine (an antiulcer drug) and zolpidem (a hypnotic drug) are derived from 











 and Alzheimer diseases
8
. 
Hence, the synthesis of fused bicyclic imidazo[1,2-a]pyridines has evoked much attention
 
as a 
result of which a variety of synthetic methodologies have been reported. The most important 
approaches are: (i) condensation of 2-aminopyridine with α-halocarbonyl compounds
9
, (ii) one 
pot condensations of aldehydes, isonitriles and 2-aminopyridines
10
, (iii) copper-catalyzed three-
component reactions of 2-aminopyridines, aldehydes and alkynes
11
. Other methods have also 
been developed within the last three decades
12
. In recent time, very few methods have been 
describing the one pot multicomponent synthesis of fused bicyclic imidazo[1,2-a]pyridines based 



















 from the reaction of  isocyanide, aromatic 
aldehydes and 2-aminopyridine. However, these methods have limitations in terms of the use of 
expensive and excess amount of catalysts, product diversity and yields. Hence, the development 
of a simple and high yielding environmentally benign protocol for the one pot multicomponent 
synthesis of fused bicyclic imidazo[1,2-a]pyridine scaffolds is still needed.  
In recent years, Iodine has proved to be a very useful catalyst in carrying out synthesis of 











. Iodine has received increasing attention as an inexpensive, non-toxic and readily 
available catalyst for organic synthesis. Iodine has high tolerance to moisture as well as air 
making it ideal catalyst. It can be easily removed from the reaction mixture by washing with 
reducing agents
27
. The use of iodine as a catalyst is not only the cost effective and 










































































Result and discussion 
First the optimization of the reaction was studied for which the reaction of 2-chloro-
pyridine-3-carbaldehyde, 5-chloro-pyridin-2-ylamine and tert-butylisocyanide was selected as a 
model (Scheme 1). It was hypothesized that a critical choice of iodine might efficiently catalyse 
the one step fusion of imidazo[1,2-a]pyridines by forming a better activated intermediate. A 
preliminary examination showed that I2 in ethanol among several solvents effectively catalyzed 
the model reaction. Upon varying the temperature of the reaction from 30 to 70 
°
C, the best yield 
of 2a (table 1, entry 1) was obtained at 70 
°
C. Further increase in the temperature (70 
°
C), neither 
increased the yield nor shortened the reaction time. The time taken for complete conversion 
(monitored by TLC) and the isolated yields are recorded (Table 1). Of the reactions using 
different quantities of reactant, the best results were obtained using 1.0: 1.0: 1.2 ratios of 2-
chloro-pyridine-3-carbaldehyde, 5-chloro-pyridin-2-ylamine and tert-butylisocyanide 
respectively. When a mixture of 2-chloro-pyridine-3-carbaldehyde, 5-chloro-pyridin-2-ylamine 
and tert-butylisocyanide in ethanol was refluxed in the presence of iodine (10 mol%) at 70 
°
C for 
30 min, the fused heterocyclic products, N-tert-butyl-6-chloro-2-(2-chloropyridin-3-yl)H-
imidazo[1,2-a]pyridin-3-amine (2a) was obtained in excellent yield (96%). At the same time, 
decreasing the amount of catalyst from 10 mol% to 5 mol% lowered the imidazo[1,2-a]pyridine 
yield (65%) while increasing the amount of catalyst from 10 mol% to 20 mol% did not shown any 
significant impact on the imidazo[1,2-a]pyridine yield indicating that the above reaction condition 
was suitable for the one pot assembly.   
The role of solvents on the synthesis of imidazo[1,2-a]pyridine was then studied and the 
results are depicted (Table 2). Replacing the ethanol by chloroform produced the model in an 





































































appreciable yield (entry 7) albeit lesser than that of the one produced by the former (entry 5).  
Other solvents such as acetonitrile, THF, dioxane and DMSO accomplished the model in 
moderate yields (80-86 %, entries 1, 3, 8 and 9), while DCM, DMF and toluene produced still 
lower yields (63-79 %, entries 2, 4 and 6) respectively. 
Optimized condition was established in ethanol as a solvent system using a reaction 
temperature of 70 
°
C and a time of 30 min. This remarkable activation in reaction rate prompted 
us to explore the potential of this protocol for the synthesis of a variety of imidazo[1,2-
a]pyridines and the results are summarized (Table 1). All the aforementioned reactions proceeded 
expeditiously and delivered better to excellent product yields accommodating a wide range of 
hetero aromatic aldehydes. The overall yield ranged from 96 % of N-tert-butyl-6-chloro-2-(2-
chloropyridin-3-yl)H-imidazo[1,2-a]pyridin-3-amine (2a) (entry 1) to 81% of N-tert-butyl-6-
chloro-2-(1H-imidazol-4-yl)H-imidazo[1,2-a]pyridin-3-amine (2g) (entry 7).  
 A probable mechanistic pathway for the formation of imidazo[1,2-a]pyridine is outlined, 
(Figure 2), which is in analogy to the established mechanism as reported in the literature
29
. Iodine 
can serve as a catalyst for the reaction of 2-aminopyridine and aromatic aldehyde to give the 
corresponding imine. The subsequent attack of tert-butylisocyanide on the activated imine, 
followed by intramolecular Groebke-Blackburn-Bienayme type reaction under the reaction 
conditions, would eventually afford the final imidazo[1,2-a]pyridine. Iodine is likely to enhance 
the rate of this multicomponent reaction. 
 
Conclusion 
 In conclusion, a straightforward and efficient protocol for the one pot synthesis of 
imidazo[1,2-a]pyridine scaffold has been developed in the presence of iodine as a catalyst via 
three component reaction of aromatic aldehydes, 2-aminopyridine and tert-butylisocyanide with 
excellent yields. Mild reaction conditions, absence of tedious separation procedures, operational 





































































simplicity, clean reaction profiles, high atom economy and environmentally benign catalyst are 
the key advantages of the present MCR’s protocol. 
 
Exprimental  
General information  
The melting points were determined by open capillary method using electric melting point 
apparatus and are uncorrected. The IR spectra (KBr disc) were recorded on a Shimadzu-8400S 
FT-IR Spectrophotometer. 
1
H NMR spectra were recorded on Bruker 300 MHz spectrometer and 
13
C NMR was recorded on Bruker 400 MHz spectrometer by using CDCl3 as a solvent and TMS 
as an internal standard. The chemical shifts are expressed in δ ppm. The mass spectra were 
recorded on an Agilent-Single Quartz LC-MS. The purity of the compounds was checked by 
TLC. The elemental analyses were carried out using Elemental Vario Micro Cube CHNS Rapid 
Analyzer. All the compounds gave satisfactory elemental analysis.   
 
Typical procedure for the synthesis of N-tert-butyl-(6-chloro-imidazo[1,2-a]pyridin-3-yl)-
amine (2a).  
To a stirring solution of 2-amino-5-chloropyridine (200 mg, 1.56 mmol), 2-chloro-
pyridine-3-carbaldehyde (200 mg, 1.56 mmol) and tert-butylisocyanide (144 mg, 1.87 mmol) in 
ethanol (15 mL) was added iodine (20 mg, 10 mol %). The reaction flask was heated at 70 
°
C in 
an oil bath for 30 min. After completion of the reaction, ethanol was removed under reduced 
pressure. The residue left out was dissolved with ethyl acetate and added aqueous Na2S2O3 
solution. The organic layer was separated and aqueous layer was extracted with ethyl acetate (15 
ml X 3). The combined organic phase were washed with water, dried over anhydrous sodium 
sulfate and concentrated under reduced pressure to afford a crude product which was purified on 
silica gel using hexane and ethyl acetate (7:3).  












































































H NMR (400 MHz, 
CDCl3): δ = 0.87 (s, 9H of tert-butyl), 4.31 (s, 1H, N-H), 7.28 (dd, 1H, J = 9.6, 2.1 Hz, Ar-H), 
7.51 (t, 1H, J = 4.8 Hz, Ar-H), 7.58 (d, 1H, J = 9.6 Hz, Ar-H), 8.07 (dd, 1H, J = 7.8, 2.1 Hz, Ar-
H), 8.57 (d, 1H, J = 1.2 Hz, Ar-H), 8.69 (s, 1H, Ar-H) ppm; 
13
C NMR (400 MHz, CDCl3): δ = 
30.0, 56.9, 104.5, 110.8, 117.3, 120.7, 121.3, 121.8, 123.2, 124.5, 126.0, 127.0, 128.6, 154.5 ppm; 
LC-MS: [M+H] 335; Anal. Calcd for C16H16Cl2N4: C, 57.33: H, 4.81: N, 16.71. Found:  C, 57.21: 
H, 4.67: N, 16.57. 
 
 N-tert-butyl-6-chloro-2-(thiophen-3-yl)H-imidazo[1,2-a]pyridin-3-amine (2b) 






H NMR (400 MHz, 
CDCl3): δ = 0.95 (s, 9H of tert-butyl), 3.20 (s, 1H, N-H), 7.16 (dd, 1H, J = 9.6, 2.0 Hz, Ar-H), 
7.39 (dd, 1H, J = 7.5, 4.76 Hz, Ar-H), 7.5 (d, 1H, J = 9.24 Hz, Ar-H), 8.08 (dd, 1H, J = 7.7, 2.0 
Hz, Ar-H), 8.36 (m, 1H, Ar-H), 8.44 (m, 1H, Ar-H) ppm; 
13
C NMR (400 MHz, CDCl3): δ = 29.9, 
55.9, 117.8, 120.5, 121.7, 122.7, 125.7, 126.4, 131.1, 136.6, 140.7, 148.8, 149.2 ppm; Anal. Calcd 
for C15H16ClN3S: C, 58.91: H, 5.27: N, 13.74: S, 10.48. Found:  C, 58.72: H, 5.12: N, 13.53: S, 
10.18. 
 
 N-tert-butyl-6-chloro-2-(5-methylthiophen-2-yl)H-imidazo[1,2-a]pyridin-3-amine (2c)  






H NMR (400 MHz, 
CDCl3): δ = 1.19 (s, 9H of tert-butyl), 2.52 (s, 3H, CH3), 3.09 (s, 1H, N-H), 6.74 (m, 1H, Ar-H), 
7.06 (dd, 1H, J = 7.4, 2.0 Hz, Ar-H), 7.36 (d, 1H, J = 4.0 Hz, Ar-H), 7.44 (d, 1H, J = 8 Hz, Ar-H), 
8.20 (d, 1H, J = 1.6 Hz, Ar-H) ppm; 
13
C NMR (400 MHz, CDCl3): δ = 15.3, 30.5, 56.8, 117.3, 
119.9, 121.4, 122.8, 125.3, 125.6, 126.5, 132.3, 140.0, 140.1 ppm; Anal. Calcd for C16H18ClN3S: 
C, 60.08: H, 5.67: N, 13.14: S, 10.02. Found:  C, 59.91: H, 5.54: N, 13.01: S, 9.97.  












































































H NMR (400 MHz, 
CDCl3): δ = 1.20 (s, 9H of tert-butyl), 2.96 (s, 1H, N-H, D2O exchangeable), 7.03 (d, 1H, J = 3.88 
Hz, Ar-H), 7.03 (dd, 1H, J = 1.96, 2.0 Hz, Ar-H), 7.33 (d, 1H, J = 3.92 Hz, Ar-H), 7.43 (d, 1H, J 
= 8 Hz, Ar-H), 8.18 (m, 1H, Ar-H) ppm; 
13
C NMR (400 MHz, CDCl3): δ = 30.0, 56.7, 109.8, 
113.3, 117.5, 120.0, 120.7, 121.6, 124.7, 126.0, 130.8, 140.6, 151.8 ppm; Anal. Calcd for 
C15H15BrClN3S: C, 46.83: H, 3.93: N, 10.92: S, 8.33. Found:  C, 46.74: H, 3.80: N, 10.80: S, 
8.21. 
 
 N-tert-butyl-2-(5-bromofuran-2-yl)-6-chloroH-imidazo[1,2-a]pyridin-3-amine (2e) 






H NMR (400 MHz, 
CDCl3): δ = 1.18 (s, 9H of tert-butyl), 3.45 (s, 1H, N-H), 6.43 (d, 1H, J = 4.0 Hz, Ar-H), 6.84 (d, 
1H, J = 3.4 Hz, Ar-H), 7.08 (dd, 1H, J = 9.3, 1.9 Hz, Ar-H), 7.40 (d, 1H, J = 9.9 Hz, Ar-H), 8.25 
(m, 1H, Ar-H) ppm; 
13
C NMR (400 MHz, CDCl3): δ = 30.0, 56.7, 109.8, 113.3, 117.5, 120.0, 
120.7, 121.6, 124.7, 126.0, 130.8, 140.6, 151.8 ppm; Anal. Calcd for C15H15BrClN3O: C, 48.87: 
H, 4.10: N, 11.40. Found:  48.74: H, 4.01: N, 11.29. 
 
 N-tert-butyl-2-(benzofuran-2-yl)-6-chloroH-imidazo[1,2-a]pyridin-3-amine (2f)  






H NMR (400 MHz, 
CDCl3): δ = 1.16 (s, 9H of tert-butyl), 4.74 (s, 1H, N-H), 7.23-8.53 (m, 8H, Ar-H) ppm; 
13
C NMR 
(400 MHz, CDCl3): δ = 29.55, 57.31, 105.08, 114.07, 114.11, 117.26, 117.92, 121.14, 131.17, 
140.89, 140.93, 145.86, 149.71, 150.56, 152.50 ppm; Anal. Calcd for C19H18ClN3O: C, 67.16: H, 
5.34: N, 12.37. Found:  C, 66.93: H, 5.06: N, 12.30.  
 
N-tert-butyl-6-chloro-2-(1H-imidazol-4-yl)H-imidazo[1,2-a]pyridin-3-amine (2g) 









































































 (N-H of tert-butyl), 3216 cm
-1
 (N-H of  
imidazole); 
1
H NMR (400 MHz, CDCl3): δ = 1.18 (s, 9H of tert-butyl), 4.15 (s, 1H, N-H of tert-
butyl), 7.05 (dd, 1H, J = 9.5, 1.9 Hz, Ar-H), 7.37 (d, 1H, J = 8.0 Hz, Ar-H), 7.59 (s, 1H, Ar-H), 
7.68 (s, 1H, Ar-H), 8.27 (d, 1H, J = 1.60, Ar-H), 11.68 (s, 1H, N-H of imidazole) ppm;
 13
C NMR 
(400 MHz, CDCl3): 30.2, 57.0, 116.8, 119.7, 121.6, 125.2, 128.2, 133.1, 134.8, 140.3 ppm; Anal. 
Calcd for C14H16ClN5: C, 58.03: H, 5.57: N, 24.17. Found: C, 57.87: H, 5.42: N, 24.03.  
 
N-tert-butyl-6-chloro-2-(4-chloro-2-ethyl-1H-imidazol-5-yl)H-imidazo[1,2-a]pyridin-3-
amine (2h)  




(N-H of tert-butyl), 3235 cm
-1
 (N-H of  
imidazole); 
1
H NMR (300 MHz, CDCl3): δ = 1.05 (s, 9H of tert-butyl), 1.2 (t, 3H, J = 7.5 Hz, 
CH3 of C2H5), 2.58 (q, 2H, J = 7.5 Hz, CH2 of C2H5), 5.3 (s, 1H, N-H of tert-butyl), 7.11 (d, 1H, J 
= 9.3 Hz, Ar-H), 7.44 (d, 1H, J = 9.3 Hz, Ar-H), 8.36 (s, 1H, Ar-H), 11.63 (s, 1H, N-H of 
imidazole) ppm; 
13
C NMR (400 MHz, CDCl3): δ = 14.02, 26.86, 30.22, 57.06, 115.76, 119.61, 
121.33, 125.25, 128.23, 133.16, 134.86, 141.31, 144.31 ppm; Anal. Calcd for C16H19Cl2N5: C, 
54.55: H, 5.44: N, 19.88. Found: C, 54.41: H, 5.35: N, 19.72.  
 
N-tert-butyl-6-chloro-2-(2-phenyl-1H-imidazol-5-yl)H-imidazo[1,2-a]pyridin-3-amine (2i) 




 (N-H of tert-butyl), 3301 cm
-1
 (N-H of 
imidazole); 
1
H NMR (400 MHz, CDCl3): δ = 0.91 (s, 9H of tert-butyl), 4.3 (s, 1H, N-H of tert-
butyl), 7.16-8.49 (m, 9H, Ar-H), 12.74 (s, 1H, N-H of imidazole) ppm; 
13
C NMR (400 MHz, 
CDCl3): δ =29.84, 57.14, 115.54, 117.14, 121.11, 124.61, 126.64, 127.24, 128.11, 128.82, 135.24, 
136.44, 138.82, 157.80 ppm; Anal. Calcd for C20H20ClN5: C, 65.66: H, 5.51: N, 19.14. Found: C, 
65.53: H, 5.40: N, 19.02.  






































































amine (2j)  






H NMR (400 MHz, CDCl3): δ = 
0.91 (s, 9H of tert-butyl), 2.29 (s, 1H, CH3 of pyrozole), 2.92 (s, 1H, N-H), 3.78 (s, 1H, N-CH3), 
7.04 (dd, 1H, J = 9.4, 1.88 Hz, Ar-H), 7.42 (d, 1H, J = 9.2 Hz, Ar-H), 8.26 (d, 1H, J = 1.4, Ar-H) 
ppm;
 13
C NMR (400 MHz, CDCl3): δ = 12.2, 28.8, 35.2, 54.8, 110.5, 116.5, 119.0, 120.3, 124.4, 
124.4, 124.6, 131.1, 139.5, 146.9 ppm; Anal. Calcd for C16H19Cl2N5: C, 54.55: H, 5.44: N, 19.88. 
Found: C, 54.49: H, 5.28: N, 19.75.  
 
N-tert-butyl-6-chloro-2-(quinolin-4-yl)H-imidazo[1,2-a]pyridin-3-amine (2k)  






H NMR (400 MHz, CDCl3): δ = 
1.21 (s, 9H of tert-butyl), 3.74 (s, 1H, N-H), 7.16-8.33 (m, 9H, Ar-H) ppm; 
13
C NMR (400 MHz, 
CDCl3): δ = 30.09, 56.85, 103.78, 110.87, 117.75, 121.17, 121.74, 123.16, 124.30, 126.13, 
128.74, 138.10, 140.30, 140.15, 143.74, 150.07, 152.00, 153.13; Anal. Calcd for C20H19ClN4: C, 
68.47: H, 5.46: N, 15.97. Found:  C, 68.24: H, 5.28: N, 15.78. 
 
 N-tert-butyl-6-chloro-2-(1H-indol-3-yl)H-imidazo[1,2-a]pyridin-3-amine (2l)  




 (N-H of tert-butyl), 3406 cm
-1
 (N-H 
of  indole); 
1
H NMR (400 MHz, CDCl3): δ = 0.95 (s, 9H of tert-butyl), 3.46 (s, 1H, N-H of tert-
butyl), 7.1-8.33 (m, 8H, Ar-H), 9.40 (s, 1H, N-H of indole) ppm; 
13
C NMR (400 MHz, CDCl3): δ 
= 30.1, 56.5, 111.6, 115.9, 120.3, 120.4, 120.8, 121.4, 122.3, 123.8, 124.9, 125.3, 125.8, 126.5, 
128.2, 129.0, 136.0 ppm; Anal. Calcd for C19H19ClN4: C, 67.35: H, 5.65: N, 16.53. Found:  C, 
67.03: H, 5.52: N, 16.40.  
 
 N-tert-butyl-6-chloro-2-(1-methyl-1H-indol-2-yl)H-imidazo[1,2-a]pyridin-3-amine (2m) 











































































H NMR (400 MHz, CDCl3): δ 
= 0.97 (s, 9H of tert-butyl), 3.94 (s, 3H, N-CH3), 5.19 (s, 1H, N-H), 6.65-8.36 (m, 8H, Ar-H) 
ppm; 
13
C NMR (400 MHz, CDCl3): δ = 29.9, 31.2, 56.2, 103.3, 109.6, 117.1, 119.7, 120.7, 121.8, 
122.1, 127.7, 138.1 ppm; Anal. Calcd for C20H21ClN4: C, 68.0: H, 6.0: N, 15.88. Found: C, 67.82: 
H, 5.85: N, 15.72. 
 
 N-tert-butyl-6-chloro-2-(4-ethoxyphenyl)H-imidazo[1,2-a]pyridin-3-amine (2n) 






H NMR (300 MHz, CDCl3): 
δ = 0.76 (s, 9H of  tert-butyl), 1.44 (t, 3H, J = 7.12 Hz, CH3 of ethoxy), 4.44 (q, 2H, J = 7.12 Hz, 
7.12 Hz, CH2 of ethoxy), 4.80 (s, 1H, N-H), 7.53-8.91 (m, 7H, Ar-H) ppm; 
13
C NMR (400 MHz, 
CDCl3): 14.2, 29.3, 56.4, 62.6, 122.5, 124.5, 126.0, 126.4, 127.3, 129.0, 131.9, 136.6, 141.7, 
145.0, 148.9, 149.7, 158.6 ppm; Anal. Calcd for C19H22ClN3O: C, 66.37: H, 6.45: N, 12.22. 
Found: C, 66.22: H, 6.31: N, 12.01.   
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Optimization of solvents at 70 
°
C for the synthesis 2a  
 
Entry Solvents Time (min) Yield (%) 
1 Acetonitrile 45 82 
2 DCM 70 79 
3 THF 40 84 
4 DMF 65 63 
5 Ethanol 30 96 
6 Toluene 50 73 

























































































































































































































































































































Figure 2. A Plausible reaction mechanism for the iodine catalysed one step fusion of 2-aryl-
imidazo[1,2-a]pyridine heterocycles.  
 




































































A facile and efficient protocol for the synthesis of novel imidazo[1,2-a]pyridines has been 
developed by one-pot reaction of aromatic aldehydes with 2-amino-5-chloropyridine and tert-
butylisocyanide in the presence of I2 in toluene at 70 °C. The present approach offers the 
advantages of simple methodology, clean, high atom-economy, mild condition, short reaction 
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